APM
BMRN icon

Avidity Partners Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Avidity Partners Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-320,000
Closed -$22.5M – 66
2024
Q3 		$22.5M Buy
+320,000
New +$26.7M 1.15% 36
2023
Q2 		– Sell
-300,575
Closed -$29.2M – 99
2023
Q1 		$29.2M Buy
+300,575
New +$31.2M 0.97% 37
2021
Q1 		– Sell
-992,900
Closed -$87.1M – 102
2020
Q4 		$87.1M Buy
+992,900
New +$78.7M 2.93% 8
2020
Q2 		– Sell
-302,000
Closed -$25.5M – 62
2020
Q1 		$25.5M Buy
+302,000
New +$26M 3.66% 5

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $15.9B AUM 60.76% 1-Year Est. Return